{"id":"placebo-nebuliser-solution","safety":{"commonSideEffects":[]},"_chembl":{"chemblId":"CHEMBL2108251","moleculeType":"Oligosaccharide"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Placebo formulations are inert preparations used as control comparators in clinical trials to distinguish genuine drug effects from placebo response. In a nebulised form, the placebo solution is inhaled via nebuliser device but delivers no therapeutic agent, allowing researchers to measure baseline disease progression and psychological/expectation-driven improvements in Phase 3 trial populations.","oneSentence":"A placebo nebuliser solution contains no active pharmaceutical ingredient and produces no direct pharmacological effect.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:27:56.463Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Clinical trial control arm (indication under investigation in Phase 3 trial not specified)"}]},"trialDetails":[{"nctId":"NCT06089317","phase":"NA","title":"Traditional Chinese Medicine Ultrasonic Atomization Treatment for Dry Eye Disease","status":"COMPLETED","sponsor":"Chinese University of Hong Kong","startDate":"2024-07-28","conditions":"Dry Eye Syndromes","enrollment":200},{"nctId":"NCT06969573","phase":"PHASE2","title":"Inhaled Treprostinil for Dyspnea and Exercise Intolerance in Mild COPD","status":"RECRUITING","sponsor":"University of Alberta","startDate":"2025-06-05","conditions":"COPD (Chronic Obstructive Pulmonary Disease)","enrollment":20},{"nctId":"NCT07450482","phase":"PHASE2","title":"Safety and Efficacy of JKN2304 Inhalation Solution in Patients With Moderate to Severe COPD","status":"COMPLETED","sponsor":"Joincare Pharmaceutical Group Industry Co., Ltd","startDate":"2025-07-22","conditions":"COPD (Chronic Obstructive Pulmonary Disease), COPD","enrollment":42},{"nctId":"NCT07285122","phase":"PHASE1","title":"Inhaled RB042 in Healthy Adult Volunteers and Healthy Adult Smokers","status":"RECRUITING","sponsor":"RAGE Bio","startDate":"2026-02-16","conditions":"Healthy, Healthy Smoker","enrollment":90},{"nctId":"NCT04708782","phase":"PHASE3","title":"Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis","status":"COMPLETED","sponsor":"United Therapeutics","startDate":"2021-06-01","conditions":"Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease","enrollment":598},{"nctId":"NCT06545500","phase":"PHASE2","title":"A Phase IIb Study of Glycopyrrolate Inhalation Solution Over 1 Week in Subjects With COPD","status":"COMPLETED","sponsor":"Verona Pharma plc","startDate":"2024-08-16","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":46},{"nctId":"NCT06624696","phase":"PHASE4","title":"Inhaling Penehyclidine to Prevent Perioperative Respiratory Adverse Events in Children at Risk Undergoing Sevoflurane Anesthesia","status":"RECRUITING","sponsor":"Sun Yat-sen University","startDate":"2024-11-12","conditions":"Respiratory Hypersensitivity, Perioperative Respiratory Adverse Events, Anticholinergics","enrollment":204},{"nctId":"NCT05943535","phase":"PHASE3","title":"Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)","status":"RECRUITING","sponsor":"United Therapeutics","startDate":"2023-10-30","conditions":"Progressive Pulmonary Fibrosis, Interstitial Lung Disease","enrollment":698},{"nctId":"NCT07345715","phase":"NA","title":"Oral Melatonin Versus Nebulized Dexmedetomidine on Emergence Agitation in Children Undergoing Adenotonsillectomy","status":"RECRUITING","sponsor":"Tanta University","startDate":"2025-07-01","conditions":"Oral Melatonin, Nebulized Dexmedetomidine, Emergence Agitation","enrollment":96},{"nctId":"NCT06580509","phase":"EARLY_PHASE1","title":"TranExamic Atomized for Pediatric Post-Operative Tonsillectomy Hemorrhage: Pilot Study","status":"NOT_YET_RECRUITING","sponsor":"The University of Texas Health Science Center at San Antonio","startDate":"2026-02","conditions":"Hemorrhage, Surgical, Tonsillar Bleeding","enrollment":12},{"nctId":"NCT06999603","phase":"PHASE2","title":"Phase 2 Study of Inhaled SNG001 in Mechanically Ventilated Patients With Respiratory Viral Infection","status":"RECRUITING","sponsor":"Synairgen Research Ltd.","startDate":"2025-09-02","conditions":"Viral Pneumonia","enrollment":550},{"nctId":"NCT06559150","phase":"PHASE2","title":"A Phase II Study of Ensifentrine in Non-Cystic Fibrosis Bronchiectasis","status":"RECRUITING","sponsor":"Verona Pharma plc","startDate":"2024-09-11","conditions":"Non-cystic Fibrosis Bronchiectasis","enrollment":180},{"nctId":"NCT05450328","phase":"PHASE2","title":"Inhaled Milrinone and Epoprostenol for the Prevention of Difficult Cardiac Pulmonary Bypass Separation","status":"NOT_YET_RECRUITING","sponsor":"Montreal Heart Institute","startDate":"2025-11-01","conditions":"Right Heart Failure, Right Ventricular Dysfunction","enrollment":141},{"nctId":"NCT04204252","phase":"PHASE3","title":"Phase III, Efficacy and Safety of \"Kamada-AAT for Inhalation\"","status":"RECRUITING","sponsor":"Kamada, Ltd.","startDate":"2019-11-25","conditions":"Alpha 1-Antitrypsin Deficiency","enrollment":220},{"nctId":"NCT07133880","phase":"PHASE4","title":"Compare the Effects of Nebulizer Versus Inhaler Based Therapy for COPD Using Long-acting Bronchodilators","status":"RECRUITING","sponsor":"University of Tennessee Graduate School of Medicine","startDate":"2023-12-05","conditions":"COPD (Chronic Obstructive Pulmonary Disease)","enrollment":72},{"nctId":"NCT05255991","phase":"PHASE3","title":"Multinational Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis","status":"COMPLETED","sponsor":"United Therapeutics","startDate":"2022-10-04","conditions":"Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease","enrollment":597},{"nctId":"NCT07112456","phase":"PHASE2","title":"Nebulized Ketamine Plus Standard Care vs. Standard Care Alone in Moderate to Severe Asthma Exacerbations","status":"NOT_YET_RECRUITING","sponsor":"Oman Medical Speciality Board","startDate":"2026-09-01","conditions":"Asthma Acute, Asthma Attack, Asthma Exacerbations","enrollment":100},{"nctId":"NCT04544293","phase":"PHASE3","title":"Clinical Trial of Inhaled Molgramostim Nebulizer Solution in Autoimmune Pulmonary Alveolar Proteinosis (aPAP)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Savara Inc.","startDate":"2021-05-19","conditions":"Autoimmune Pulmonary Alveolar Proteinosis","enrollment":164},{"nctId":"NCT06841640","phase":"PHASE1, PHASE2","title":"Phase 1/Phase 2a Study of AERO-007 Inhalation Solution, a Nebulized LABA/LAMA Combination for Maintenance Treatment of COPD","status":"COMPLETED","sponsor":"AeroRx Therapeutics Inc.","startDate":"2025-01-15","conditions":"COPD","enrollment":24},{"nctId":"NCT06584474","phase":"PHASE4","title":"THE EFFECT OF NEBULIZED AZITHROMYCIN AS THERAPY FOR BRONCHOPULMONARY DYSPLASIA","status":"COMPLETED","sponsor":"Alexandria University","startDate":"2024-10-02","conditions":"Bronchopulmonary Dysplasia, Premature, Ventilation, Mechanical","enrollment":100},{"nctId":"NCT07055828","phase":"NA","title":"Nebulized vs. IV Ketamine in Preventing Shivering Post Spinal Anesthesia","status":"ACTIVE_NOT_RECRUITING","sponsor":"Tanta University","startDate":"2025-05-02","conditions":"Post Spinal Anesthesia Shivering","enrollment":120},{"nctId":"NCT06201156","phase":"NA","title":"Comparison of Nebulizers vs Metered-Dose Inhalers With Spacer Device For Treatment Of Childhood Wheeze","status":"COMPLETED","sponsor":"Khyber Teaching Hospital","startDate":"2023-12-10","conditions":"Childhood Asthma With Acute Exacerbation","enrollment":160},{"nctId":"NCT06662019","phase":"PHASE1","title":"Phase I Safety Study of Inhaled N-IP-00001 to Determine Tolerability and Safety in Healthy Volunteers.","status":"COMPLETED","sponsor":"NeoTrials Pty Ltd","startDate":"2024-10-29","conditions":"Healthy","enrollment":8},{"nctId":"NCT00677365","phase":"PHASE2","title":"Safety, Tolerability and Efficacy of MP-376 Given for 28 Days to Cystic Fibrosis (CF) Patients","status":"COMPLETED","sponsor":"Amgen","startDate":"2008-06","conditions":"Cystic Fibrosis (CF)","enrollment":151},{"nctId":"NCT00739648","phase":"PHASE2","title":"A Phase 2 Study of MP-376 to Prevent Acute Exacerbations in Chronic Obstructive Pulmonary Disease (COPD) Patients","status":"COMPLETED","sponsor":"Amgen","startDate":"2008-10","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":322},{"nctId":"NCT05165485","phase":"PHASE4","title":"Phase 4 COPD and Suboptimal Inspiratory Flow Rate","status":"COMPLETED","sponsor":"Theravance Biopharma","startDate":"2022-01-07","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":404},{"nctId":"NCT06093191","phase":"PHASE4","title":"Tobramycin Inhalation Solution for Pseudomonas Aeruginosa Eradication in Bronchiectasis","status":"RECRUITING","sponsor":"Shanghai Pulmonary Hospital, Shanghai, China","startDate":"2023-09-25","conditions":"Bronchiectasis Adult, Pseudomonas Aeruginosa Infection","enrollment":364},{"nctId":"NCT06731959","phase":"PHASE2","title":"A Study to Investigate Using Inhaled Fexlamose to Treat Adult Participants Who Have Moderate to Severe COPD","status":"NOT_YET_RECRUITING","sponsor":"Aer Therapeutics","startDate":"2024-12","conditions":"COPD","enrollment":100},{"nctId":"NCT05977699","phase":"PHASE4","title":"Reversibility of Methacholine Induced Bronchoconstriction","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Saskatchewan","startDate":"2024-01-12","conditions":"Asthma","enrollment":20},{"nctId":"NCT00503490","phase":"PHASE1","title":"Safety, Pharmacokinetic and Pharmacodynamic Study of MP-376 in Patients With Cystic Fibrosis","status":"COMPLETED","sponsor":"Amgen","startDate":"2007-06","conditions":"Cystic Fibrosis","enrollment":40},{"nctId":"NCT04898114","phase":"PHASE1, PHASE2","title":"Nebulized Magnesium Sulfate and Sildenafil for Persistent Pulmonary Hypertension of Newborn","status":"RECRUITING","sponsor":"Sohag University","startDate":"2021-06-02","conditions":"Persistent Pulmonary Hypertension of Newborn","enrollment":40},{"nctId":"NCT05077917","phase":"PHASE3","title":"Cromolyn Sodium for Treatment of COVID-19 Pneumonia","status":"TERMINATED","sponsor":"Texas Tech University Health Sciences Center, El Paso","startDate":"2021-11-15","conditions":"COVID-19 Pneumonia, COVID-19 Respiratory Infection, Pneumonia, Viral","enrollment":22},{"nctId":"NCT06619210","phase":"PHASE2","title":"A Trial to Evaluate the Safety and Efficacy of HL231 Solution for Inhalation in Patients with COPD","status":"COMPLETED","sponsor":"Haisco Pharmaceutical Group Co., Ltd.","startDate":"2022-01-12","conditions":"Chronic Obstructive Pulmonary Disease (COPD)","enrollment":102},{"nctId":"NCT03766399","phase":"PHASE1","title":"A Study in Healthy Volunteers and Patients With Mild Asthma to Investigate the Safety, Anti-inflammatory Effect of Inhaled AZD0449","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2018-11-30","conditions":"Asthma","enrollment":131},{"nctId":"NCT04518410","phase":"PHASE2, PHASE3","title":"ACTIV-2: A Study for Outpatients With COVID-19","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2020-08-19","conditions":"Coronavirus, Covid19","enrollment":4044},{"nctId":"NCT05862623","phase":"PHASE1","title":"Single and Multiple Ascending Dose Study of AER-01","status":"UNKNOWN","sponsor":"Aer Therapeutics","startDate":"2023-05-26","conditions":"COPD","enrollment":72},{"nctId":"NCT02919995","phase":"PHASE2","title":"A Study of RPL554 in Patients With Cystic Fibrosis","status":"COMPLETED","sponsor":"Verona Pharma plc","startDate":"2017-02-08","conditions":"Cystic Fibrosis","enrollment":10},{"nctId":"NCT04961528","phase":"PHASE3","title":"ACid Tranexamic or Terlipressin for Initial Emergency Treatment of Mild to seVere hEmoptysis: a Randomized Trial.","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2022-03-27","conditions":"Hemoptysis","enrollment":315},{"nctId":"NCT03018756","phase":"PHASE3","title":"Nebulized Fentanyl in Patients With Mild to Moderate Interstitial Lung Disease and Chronic Dyspnea","status":"COMPLETED","sponsor":"Dr. Denis O'Donnell","startDate":"2017-01","conditions":"Interstitial Lung Disease","enrollment":21},{"nctId":"NCT00147199","phase":"PHASE3","title":"Clinical Investigation Into Inhaled Treprostinil Sodium in Patients With Severe Pulmonary Arterial Hypertension (PAH)","status":"COMPLETED","sponsor":"United Therapeutics","startDate":"2005-06","conditions":"Pulmonary Hypertension","enrollment":235},{"nctId":"NCT03460704","phase":"PHASE3","title":"Trial in Non-cystic Fibrosis Bronchiectasis Patients With Chronic Lung Infections Treated With Colistimethate Sodium.","status":"TERMINATED","sponsor":"Zambon SpA","startDate":"2018-01-29","conditions":"Non Cystic Fibrosis Bronchiectasis","enrollment":287},{"nctId":"NCT04765033","phase":"PHASE4","title":"Trial on The Efficacy of Hypertonic Saline on Non-CF CSLD.","status":"COMPLETED","sponsor":"University of Malaya","startDate":"2021-02-04","conditions":"Bronchiectasis","enrollment":46},{"nctId":"NCT03496623","phase":"PHASE3","title":"A Phase 3 Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Participants With Pulmonary Hypertension (PH) Due to Chronic Obstructive Pulmonary Disease (COPD)","status":"TERMINATED","sponsor":"United Therapeutics","startDate":"2018-05-08","conditions":"Pulmonary Hypertension, Chronic Obstructive Pulmonary Disease","enrollment":188},{"nctId":"NCT03093974","phase":"PHASE3","title":"Efficacy and Safety of Inhaled CMS in Bronchiectasis Subjects With Chronic P. Aeruginosa Infection. (PROMIS-I)","status":"COMPLETED","sponsor":"Zambon SpA","startDate":"2017-06-06","conditions":"Non Cystic Fibrosis Bronchiectasis","enrollment":377},{"nctId":"NCT04535986","phase":"PHASE3","title":"A Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of Ensifentrine in Patients With COPD","status":"COMPLETED","sponsor":"Verona Pharma plc","startDate":"2020-09-29","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":763},{"nctId":"NCT06119438","phase":"NA","title":"Aromatherapy on Pain and Anxiety of the Patients Undergoing Prostate Biopsy","status":"COMPLETED","sponsor":"Mersin Training and Research Hospital","startDate":"2020-01-01","conditions":"Aromatherapy, Prostate Cancer, Anxiety","enrollment":120},{"nctId":"NCT04542057","phase":"PHASE3","title":"A Phase 3 Trial to Evaluate the Safety and Efficacy of Ensifentrine in Patients With COPD","status":"COMPLETED","sponsor":"Verona Pharma plc","startDate":"2020-09-22","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":790},{"nctId":"NCT05083117","phase":"PHASE2","title":"Safety and Efficacy of Inhaled XW001 For Hospitalized COVID-19 Patients Requiring Oxygen Therapy","status":"WITHDRAWN","sponsor":"Sciwind Biosciences APAC CO Pty. Ltd.","startDate":"2021-10-30","conditions":"COVID-19 Acute Respiratory Distress Syndrome","enrollment":""},{"nctId":"NCT05268198","phase":"EARLY_PHASE1","title":"SAD Study of APR002 Investigating the Safety/Tolerability, Pharmacokinetics/Pharmacodynamics in Healthy Subjects","status":"COMPLETED","sponsor":"Global Health Drug Discovery Institute","startDate":"2023-03-20","conditions":"COVID-19","enrollment":42},{"nctId":"NCT04569877","phase":"PHASE2","title":"GM-CSF Inhalation to Prevent ARDS in COVID-19 Pneumonia","status":"COMPLETED","sponsor":"University of Giessen","startDate":"2020-09-24","conditions":"Severe Acute Respiratory Syndrome (SARS) Pneumonia, COVID-19 Pneumonia","enrollment":63},{"nctId":"NCT02702180","phase":"PHASE2","title":"Efficacy and Safety of Inhaled Molgramostim (rhGM-CSF) in Autoimmune Pulmonary Alveolar Proteinosis","status":"COMPLETED","sponsor":"Savara Inc.","startDate":"2016-03-21","conditions":"Autoimmune Pulmonary Alveolar Proteinosis","enrollment":139},{"nctId":"NCT04732949","phase":"PHASE3","title":"Study to Assess Efficacy and Safety of Inhaled Interferon-β Therapy for COVID-19","status":"COMPLETED","sponsor":"Synairgen Research Ltd.","startDate":"2021-01-12","conditions":"Severe Acute Respiratory Syndrome Coronavirus 2, COVID-19","enrollment":623},{"nctId":"NCT05766436","phase":"NA","title":"Nebulized Dexmedetomidine VS ODF Melatonin for Peri Operative Anxiety and Emergence Agitation in Pediatric Day Surgery","status":"UNKNOWN","sponsor":"nada moahmed aboelrouse","startDate":"2023-03-15","conditions":"Anxiety Acute, Emergence Agitation","enrollment":50},{"nctId":"NCT04903730","phase":"PHASE1","title":"Safety, Tolerability, & Pharmacokinetics Study of Single & Multiple Inhaled Doses of Imatinib Inhalation Solution","status":"COMPLETED","sponsor":"Aerami Therapeutics","startDate":"2021-05-24","conditions":"Pulmonary Arterial Hypertension","enrollment":83},{"nctId":"NCT02630316","phase":"PHASE2, PHASE3","title":"Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE","status":"COMPLETED","sponsor":"United Therapeutics","startDate":"2017-02-03","conditions":"Pulmonary Hypertension, Interstitial Lung Disease, Combined Pulmonary Fibrosis and Emphysema","enrollment":326},{"nctId":"NCT04027322","phase":"PHASE2, PHASE3","title":"Inhaled Steroids for Acute Pharyngitis.","status":"COMPLETED","sponsor":"Oman Medical Speciality Board","startDate":"2019-06-01","conditions":"Acute Pharyngitis","enrollment":200},{"nctId":"NCT03219164","phase":"PHASE3","title":"Study of Aztreonam for Inhalation in Children With Cystic Fibrosis and New Infection of the Airways by Pseudomonas Aeruginosa Bacteria","status":"TERMINATED","sponsor":"Gilead Sciences","startDate":"2017-11-28","conditions":"Pseudomonas Aeruginosa Respiratory Tract Infection/Colonization, Cystic Fibrosis","enrollment":149},{"nctId":"NCT03573817","phase":"PHASE3","title":"A 42-day Parallel Group Safety Study of Revefenacin and Formoterol, Administered in Sequence and as a Combination, in Participants With COPD","status":"COMPLETED","sponsor":"Mylan Inc.","startDate":"2018-05-31","conditions":"Chronic Obstructive Pulmonary Disease (COPD)","enrollment":122},{"nctId":"NCT05229510","phase":"PHASE1","title":"Safety, Tolerability, and Pharmacokinetics of Inhaled Virazole Administered Via Air-Jet Nebulizer in Healthy Volunteers","status":"COMPLETED","sponsor":"Bausch Health Americas, Inc.","startDate":"2021-03-12","conditions":"Healthy","enrollment":32},{"nctId":"NCT00887406","phase":"PHASE1","title":"Study of GSK961081 in Healthy Volunteer Subjects","status":"COMPLETED","sponsor":"Theravance Biopharma","startDate":"2005-11-07","conditions":"Pulmonary Disease, Chronic Obstructive","enrollment":46},{"nctId":"NCT05035524","phase":"NA","title":"A Randomized Controlled Trial to Investigate The Role of Adjuvant Inhalable Sodium Bicarbonate Solution 8.4% in Treatment of COVID-19","status":"UNKNOWN","sponsor":"Mansoura University","startDate":"2021-09-01","conditions":"COVID-19 Pneumonia, Covid19, COVID-19 Acute Respiratory Distress Syndrome","enrollment":340},{"nctId":"NCT04848350","phase":"NA","title":"Use of Inhaler Aromatherapy During SWL","status":"COMPLETED","sponsor":"Mersin Training and Research Hospital","startDate":"2020-06-01","conditions":"Pain, Procedural, Aromatherapy, Anxiety","enrollment":120},{"nctId":"NCT04187508","phase":"PHASE2","title":"A Study to Evaluate the Effect of AZD8154 Administered Via Nebulizer Once Daily in Subjects With Mild Allergic Asthma Challenged With an Inhaled Allergen","status":"WITHDRAWN","sponsor":"AstraZeneca","startDate":"2020-02-06","conditions":"Asthma","enrollment":""},{"nctId":"NCT04328636","phase":"PHASE1, PHASE2","title":"Nebulized MgSO4 in Persistent Pulmonary Hypertension of Newborn","status":"COMPLETED","sponsor":"Sohag University","startDate":"2017-11-01","conditions":"Persistent Fetal Circulation, Persistent Pulmonary Hypertension of the Newborn, PPHN","enrollment":28},{"nctId":"NCT03202394","phase":"PHASE2","title":"Evaluation of Safety & Efficacy of BIO-11006 Inhalation Solution in Patients With ARDS","status":"COMPLETED","sponsor":"BioMarck Pharmaceuticals, Ltd.","startDate":"2017-08-05","conditions":"Respiratory Distress Syndrome, Adult","enrollment":38},{"nctId":"NCT04385836","phase":"EARLY_PHASE1","title":"Trial of Alpha One Antitrypsin Inhalation in Treating Patient With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)","status":"UNKNOWN","sponsor":"Ministry of Health, Saudi Arabia","startDate":"2020-06-01","conditions":"Coronavirus","enrollment":150},{"nctId":"NCT01357447","phase":"PHASE1","title":"Pulmozyme for Sjogren's Associated Cough","status":"WITHDRAWN","sponsor":"UConn Health","startDate":"2011-05","conditions":"Sjogren's Syndrome, Cough","enrollment":""},{"nctId":"NCT02482402","phase":"PHASE2","title":"Iloprost for Bridging to Heart Transplantation in PH","status":"WITHDRAWN","sponsor":"Heidelberg University","startDate":"2015-02","conditions":"Chronic Left Ventricular Failure, Pulmonary Hypertension","enrollment":""},{"nctId":"NCT00993707","phase":"PHASE2","title":"Safety Study of CTX-100 Inhalation Solution (Formerly ETX-100)","status":"COMPLETED","sponsor":"Turino, Gerard, M.D.","startDate":"2010-11","conditions":"Chronic Obstructive Pulmonary Disease (COPD)","enrollment":11},{"nctId":"NCT02095626","phase":"PHASE2","title":"Study in Intensive Care Patients Regarding the Effect of Inhaled AP-301 After Primary Graft Dysfunction After Lung Transplantation","status":"COMPLETED","sponsor":"Apeptico Forschung und Entwicklung GmbH","startDate":"2013-06","conditions":"PGD Primary Graft Dysfunction","enrollment":20},{"nctId":"NCT03673670","phase":"PHASE2","title":"Bronchodilator Effect of RPL554 Administered in Addition to Tiotropium/Olodaterol in Patients With COPD","status":"COMPLETED","sponsor":"Verona Pharma plc","startDate":"2018-07-16","conditions":"COPD","enrollment":79},{"nctId":"NCT03623022","phase":"PHASE1","title":"Effects of 20,000 EU of Clinical Center Reference Endotoxin (CCRE) Versus Placebo(ENDOHEART)","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2018-10-17","conditions":"Healthy","enrollment":15},{"nctId":"NCT02605824","phase":"PHASE4","title":"Clinical Trial of NAC in Asthma","status":"TERMINATED","sponsor":"University of California, San Francisco","startDate":"2016-03","conditions":"Asthma","enrollment":1},{"nctId":"NCT03011632","phase":"PHASE4","title":"Response of the Airway in Sinusitis and Asthma","status":"COMPLETED","sponsor":"Medical University of Lodz","startDate":"2017-01","conditions":"Sinusitis, Asthma","enrollment":150},{"nctId":"NCT03118765","phase":"PHASE2","title":"Pharmacodynamic and Pharmacokinetic Dose Ranging Study of Tiotropium Bromide Administered Via Inhalation Solution in Patients With Chronic Obstructive Pulmonary Disease (COPD)","status":"COMPLETED","sponsor":"Glenmark Specialty S.A.","startDate":"2017-03-24","conditions":"Mild to Moderate Chronic Obstructive Pulmonary Disease (COPD)","enrollment":155},{"nctId":"NCT04016220","phase":"PHASE1","title":"Nebulized Budesonide Combined With Systemic Corticosteroid in Acute Severe Asthma","status":"UNKNOWN","sponsor":"University of Monastir","startDate":"2019-05-20","conditions":"Acute Asthma","enrollment":60},{"nctId":"NCT02291016","phase":"NA","title":"COPD Aerosol Study Comparing the Efficacy of Nebulizers Versus Dry Powder Inhalers","status":"COMPLETED","sponsor":"University of Tennessee Graduate School of Medicine","startDate":"2015-02","conditions":"COPD Exacerbation","enrollment":7},{"nctId":"NCT01594827","phase":"PHASE2","title":"Persistent Methicillin Resistant Staphylococcus Aureus Eradication Protocol (PMEP)","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2012-10","conditions":"Cystic Fibrosis","enrollment":29},{"nctId":"NCT02491684","phase":"PHASE2","title":"A Study in Asthma Patients to Evaluate Efficacy, Safety and Tolerability of 14 Days Once Daily Inhaled Interferon Beta-1a After the Onset of Symptoms of an Upper Respiratory Tract Infection","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2015-07-21","conditions":"Asthma","enrollment":121},{"nctId":"NCT02029040","phase":"NA","title":"Nebulized 3% Hypertonic Saline in the Treatment of Acute Bronchiolitis","status":"COMPLETED","sponsor":"University of Texas Southwestern Medical Center","startDate":"2013-12","conditions":"Acute Bronchiolitis","enrollment":52},{"nctId":"NCT01696214","phase":"PHASE4","title":"A Pilot Study to Determine the Feasibility and Utility of Implementing of the Full Scale TOM Trial","status":"COMPLETED","sponsor":"University of California, San Diego","startDate":"2012-10","conditions":"Asthma","enrollment":20},{"nctId":"NCT02679729","phase":"PHASE1","title":"To Assess the Safety, Tolerability and Pharmacokinetics of AZD5634 Following Inhaled and Intravenous (IV)Dose Administration","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2016-02-11","conditions":"Cystic Fibrosis","enrollment":63},{"nctId":"NCT01426009","phase":"PHASE2","title":"Study to Investigate the Dose Response, Safety and Efficacy of Nebulized EP-101(SUN101) in Patients With Chronic Obstructive Pulmonary Disease (COPD): GOLDEN-1 Study","status":"COMPLETED","sponsor":"Sunovion Respiratory Development Inc.","startDate":"2011-08","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":140},{"nctId":"NCT02951312","phase":"PHASE2","title":"Assessment of the Safety and Ability of a Once-a-day Dose of an Orally Inhaled Medicine [ie, Glycopyrrolate Inhalation Solution = GIS] to Improve Airflow in the Lungs When Delivered With an Electronic eFlow Nebulizer System in Patients With Chronic Obstructive Pulmonary Disease (COPD)","status":"COMPLETED","sponsor":"Sunovion Respiratory Development Inc.","startDate":"2009-05","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":12},{"nctId":"NCT02948582","phase":"PHASE2","title":"Assessment of the Safety and Ability of a Once-a-day Dose of an Orally Inhaled Medicine [i.e., Glycopyrrolate Inhalation Solution = GIS] to Improve Airflow in the Lungs When Delivered Using an eFlow Nebulizer in Patients With Chronic Obstructive Pulmonary Disease (COPD)","status":"COMPLETED","sponsor":"Sunovion Respiratory Development Inc.","startDate":"2010-07","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":42},{"nctId":"NCT02796651","phase":"PHASE2","title":"Formoterol Dose Ranging Study (ACHIEVE Duaklir USA Phase IIb)","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2016-06-30","conditions":"Chronic Obstructive Pulmonary Disease - COPD","enrollment":132},{"nctId":"NCT03383939","phase":"NA","title":"Inhaled A1AT in Adult Stable Bronchiectasis","status":"COMPLETED","sponsor":"Hospital Universitari Vall d'Hebron Research Institute","startDate":"1996-06-01","conditions":"Bronchiectasis Adult","enrollment":20},{"nctId":"NCT02262078","phase":"PHASE2","title":"Inhaled Sodium Nitrite on Heart Failure With Preserved Ejection Fraction","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2014-10","conditions":"Heart Failure","enrollment":26},{"nctId":"NCT02141191","phase":"PHASE1","title":"A Study of Lung Clearance After Hypertonic Saline Delivery Using the tPAD Device","status":"COMPLETED","sponsor":"University of Pittsburgh","startDate":"2014-06","conditions":"Cystic Fibrosis","enrollment":12},{"nctId":"NCT01155752","phase":"PHASE3","title":"Pulmozyme in Cystic Fibrosis With Sinusitis","status":"WITHDRAWN","sponsor":"Milton S. Hershey Medical Center","startDate":"2013-07","conditions":"Sinusitis, Cystic Fibrosis","enrollment":""},{"nctId":"NCT02612051","phase":"PHASE1","title":"First Time in Human (FTIH) Study of GSK3008348 in Healthy Volunteers and Idiopathic Pulmonary Fibrosis Patients","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2015-12-04","conditions":"Idiopathic Pulmonary Fibrosis","enrollment":40},{"nctId":"NCT01031706","phase":"NA","title":"Effect of Hypertonic Saline on Mucus Clearance in Children Ages 5-12 With Cystic Fibrosis","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2009-09","conditions":"Cystic Fibrosis","enrollment":23},{"nctId":"NCT02468908","phase":"PHASE1","title":"Inhaled Molgramostim (rhGM-CSF) in Healthy Adult Subjects","status":"COMPLETED","sponsor":"Savara Inc.","startDate":"2015-05","conditions":"Pulmonary Alveolar Proteinosis, Bronchiectasis, Cystic Fibrosis","enrollment":42},{"nctId":"NCT00434993","phase":"PHASE2, PHASE3","title":"Drug Study of Albuterol to Treat Acute Lung Injury","status":"TERMINATED","sponsor":"National Heart, Lung, and Blood Institute (NHLBI)","startDate":"2007-08","conditions":"Respiratory Distress Syndrome, Adult","enrollment":282},{"nctId":"NCT02427165","phase":"PHASE2","title":"Comparison of RPL554 With Placebo and Salbutamol in Asthmatic Patients","status":"COMPLETED","sponsor":"Verona Pharma plc","startDate":"2015-04","conditions":"Asthma","enrollment":29},{"nctId":"NCT01082367","phase":"PHASE3","title":"Randomized, Controlled Study of CF Patients Between 3 Months and Less Than 7 Years","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2010-04","conditions":"Treatment of Early Pulmonary Infections With P. Aeruginosa in Cystic Fibrosis Patients","enrollment":50},{"nctId":"NCT01945944","phase":"PHASE1, PHASE2","title":"Nebulized Hypertonic Saline for Mechanically Ventilated Children","status":"COMPLETED","sponsor":"University Hospitals Cleveland Medical Center","startDate":"2013-10","conditions":"Respiratory Failure","enrollment":18},{"nctId":"NCT01560234","phase":"PHASE1","title":"AZD8848 Single Ascending Dose Study","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2012-05","conditions":"Healthy","enrollment":47},{"nctId":"NCT01641822","phase":"PHASE3","title":"Phase 3 Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy Regimen for the Treatment of Chronic Pseudomonas Aeruginosa Infection in Patients With CF","status":"COMPLETED","sponsor":"Gilead Sciences","startDate":"2012-12","conditions":"Cystic Fibrosis","enrollment":107},{"nctId":"NCT00017693","phase":"PHASE2","title":"Recombinant Human IL-4 Receptor Used in Treatment of Asthma","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"1998-05","conditions":"Asthma","enrollment":62}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":4,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Nebulizer","Atomizer"],"phase":"phase_3","status":"active","brandName":"Placebo Nebuliser solution","genericName":"Placebo Nebuliser solution","companyName":"GlaxoSmithKline","companyId":"gsk","modality":"Small molecule","firstApprovalDate":"","aiSummary":"A placebo nebuliser solution contains no active pharmaceutical ingredient and produces no direct pharmacological effect. Used for Clinical trial control arm (indication under investigation in Phase 3 trial not specified).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":2,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}